Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Orlandi R."'
Autor:
Rybinska I; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Sandri M; Data Methods and Systems Statistical Laboratory, University of Brescia, 25121 Brescia, Italy., Bianchi F; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Orlandi R; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Gasparini P; Genomic Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Campiglio M; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Paolini B; Anatomic Pathology A Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Sfondrini L; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, 20133 Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Triulzi T; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Publikováno v:
Cells [Cells] 2020 Feb 13; Vol. 9 (2). Date of Electronic Publication: 2020 Feb 13.
Autor:
Giussani M; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Landoni E; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Merlino G; Biomarkers Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Turdo F; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Veneroni S; Tissue Biobank, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Paolini B; Anatomic Pathology A Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cappelletti V; Biomarkers Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Miceli R; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Orlandi R; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Triulzi T; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2018 Aug; Vol. 233 (8), pp. 6280-6290. Date of Electronic Publication: 2018 Mar 09.
Autor:
Dugo M; Functional Genomic and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: matteo.dugo@istitutotumori.mi.it., Huang X; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. Electronic address: drxiaoyanhuang@aliyun.com., Iorio MV; Start Up Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marilena.iorio@istitutotumori.mi.it., Cataldo A; Start Up Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: alessandra.cataldo@istitutotumori.mi.it., Tagliabue E; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: elda.tagliabue@istitutotumori.mi.it., Daidone MG; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: mariagrazia.daidone@istitutotumori.mi.it., Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. Electronic address: wujiong1122@vip.sina.com., Orlandi R; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: rosaria.orlandi@istitutotumori.mi.it.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2018 Jun; Vol. 39, pp. 46-52. Date of Electronic Publication: 2018 Mar 26.
Autor:
Sangaletti S; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: sabina.sangaletti@istitutotumori.mi.it., Tripodo C; Tumor Immunology Unit, Human Pathology Section, Department of Health Science, Palermo University School of Medicine, 90129 Palermo, Italy., Santangelo A; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Castioni N; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Portararo P; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Gulino A; Tumor Immunology Unit, Human Pathology Section, Department of Health Science, Palermo University School of Medicine, 90129 Palermo, Italy., Botti L; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Parenza M; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Cappetti B; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Orlandi R; Molecular Targets Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Tagliabue E; Molecular Targets Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Cell reports [Cell Rep] 2016 Sep 27; Vol. 17 (1), pp. 233-248.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosaria Orlandi, Mario P. Colombo, Claudia Chiodoni, Mariella Parenza, Sabina Sangaletti, Barbara Cappetti, Claudio Tripodo, Nadia Castioni, Paola Portararo, Elda Tagliabue, Alessandra Santangelo, Laura Botti, Alessandro Gulino
Publikováno v:
Cell Reports, Vol 17, Iss 1, Pp 233-248 (2016)
SummaryThe extracellular matrix (ECM) contributes to the biological and clinical heterogeneity of breast cancer, and different prognostic groups can be identified according to specific ECM signatures. In high-grade, but not low-grade, tumors, an ECM